Follow the IMS Health Holdings, Inc. stock price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was filed on 12 February 2016 (Levée d'options). Among the most active insiders: Fernandez Jose Luis. Every trade is accessible without an account.
Analysts rate IMS Health Holdings, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
4 of 4 declarations
IMS Health Holdings, Inc. is a company that provides data and analytics for the healthcare sector. It assists pharmaceutical and biotechnology companies in making informed decisions through accurate market insights.